A 32-year-old man with newly diagnosed HIV infection (CD4 count 180 cells/µL, viral load 150,000 copies/mL) presents with a 2-week history of progressive dyspnea, fever, and dry cough. Chest X-ray shows bilateral interstitial infiltrates. He has not yet started antiretroviral therapy. What is the most appropriate next step in management?

Explanation

## Clinical Context This patient presents with classic features of **Pneumocystis jirovecii pneumonia (PCP)** in advanced HIV disease: - CD4 count <200 cells/µL (major risk factor) - Subacute dyspnea, fever, dry cough - Bilateral interstitial infiltrates on CXR ## Diagnostic & Management Approach **Key Point:** In resource-limited settings and when CD4 is <200 cells/µL with respiratory symptoms, empirical PCP treatment is justified while awaiting confirmatory diagnosis. ### Diagnostic Confirmation - **Induced sputum microscopy** (first-line, non-invasive, ~60% sensitivity) - **Bronchoalveolar lavage (BAL)** if sputum negative (>90% sensitivity) - Staining: Giemsa, immunofluorescence, or silver stain ### Treatment Initiation 1. **Empirical TMP-SMX** (high-dose) — first-line PCP therapy - Start immediately; do not delay for diagnostic confirmation if clinical suspicion is high - Continue for 21 days 2. **Adjunctive corticosteroids** (prednisone) if PaO~2~ <70 mmHg or A-a gradient >35 mmHg 3. **ART initiation** within 2 weeks of PCP treatment (not immediately, to avoid immune reconstitution inflammatory syndrome [IRIS]) **High-Yield:** The WHO and CDC recommend starting ART in advanced HIV with opportunistic infections within 2 weeks (not immediately) to reduce IRIS risk while maintaining immune recovery. **Clinical Pearl:** Delaying ART by 2 weeks in the setting of PCP does not compromise long-term outcomes and reduces IRIS-related morbidity. ## Why This Approach? | Aspect | Rationale | |--------|----------| | **Diagnostic step** | Confirms PCP; guides future prophylaxis decisions | | **Empirical therapy** | CD4 <200 + clinical picture = high PCP probability; do not delay | | **Timing of ART** | 2-week window balances immune recovery and IRIS prevention | | **Monitoring** | Clinical response in 5–7 days; CXR may worsen initially (IRIS) | **Mnemonic: PCP in Advanced HIV — FAST** - **F**ibreoptic bronchoscopy (if sputum negative) - **A**RT within 2 weeks (not immediately) - **S**teroids if hypoxia (PaO~2~ <70 mmHg) - **T**MP-SMX empirically (start now, confirm later) [cite:Harrison 21e Ch 197]